Kelso Pharma
PrivateLast Round
Corporate Funding
Mar 27, 2025
Total Funding Raised
$180M
Company Overview
Kelso Pharma is a specialty pharmaceutical company that acquires and commercializes innovative, value-added medicines across Europe.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology
Business Model
B2G
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kelso Pharma Comps
Public and private peers based on sector, stage, and business model.
Kelso Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Mar 27, 2025 | ||||
| Private Equity | Jan 12, 2022 |
Key People
Founding team and executive leadership
Kelso Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Apposite Capital | Corporate Funding, Private Equity |
| Kartesia | Corporate Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 5, 2026
Grew 20% QoQ, from 15 to 18 employees.
- Jun 1, 2025
Grew 63% QoQ from 8 to 13 employees.
Kelso Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Kelso Pharma's valuation, stock price, and market status.
